Advocates and figures on both sides of the aisle have reacted to the U.S. Supreme Court’s unanimous decision Thursday that pro-life doctors don’t have standing to challenge the U.S. Food and Drug Administration’s approval and loosened regulation of the abortion drug mifepristone.
The ruling comes less than two years after the high court determined in Dobbs v. Jackson Women’s Health Organization that the U.S. Constitution does not contain a right to abortion.
The Dobbs decision, which overturned the Roe v. Wade ruling that legalized abortion nationwide, is credited with bringing the issue of abortion back to the forefront of American politics.
Get Our Latest News for FREE
Subscribe to get daily/weekly email with the top stories (plus special offers!) from The Christian Post. Be the first to know.
While pro-lifers hoped the Supreme Court would build on the momentum from Dobbs by invalidating the FDA’s actions that have led to increased usage of chemical abortion, such an outcome did not materialize.
The following pages highlight seven reactions to the U.S. Supreme Court’s decision in FDA v. Alliance for Hippocratic Medicine.
Ryan Foley is a reporter for The Christian Post. He can be reached at: ryan.foley@christianpost.com
